Indonesia receives first 1.6 million pneumococcal vaccine doses through the Gavi Advanced Market Commitment mechanism to protect children against pneumonia

Once at scale, the vaccines will be used to prevent 500,000 pneumonia cases and 10,000 deaths in the country each year.

08 April 2021
Vaccine PCV

JAKARTA, 08 April 2021 – Aimed at protecting children against pneumonia, Indonesia today received the first 1.6 million doses of pneumococcal conjugate vaccine (PCV) at a significantly reduced cost through the Advanced Market Commitment mechanism.

The doses, procured for the first time via UNICEF, are part of a multi-year vaccine rollout plan to prevent 500,000 childhood pneumonia cases, 30,000 hospitalizations and 10,000 deaths in the country each year.

While Indonesia has achieved major public health gains in recent years, challenges remain in reducing the number of preventable child deaths. Pneumonia and diarrhoea continue to be the main causes of child mortality in the post-newborn period, with approximately 20,000 pneumonia deaths per year.

Many child deaths are preventable through immunization, which is one of the most cost-effective interventions to prevent pneumococcal infections and stop them from spreading to others. With five million babies born in Indonesia each year, the Government of Indonesia aims to reach them all by 2024, through an ambitious implementation plan.

Minister of Health of the Republic of Indonesia, Budi G. Sadikin, said, “The Ministry of Health is committed to maintaining essential health services, including the continuity of PCV immunization. The vaccines we received today will be used for the implementation of PCV immunization in West Nusa Tenggara and Bangka Belitung Provinces and for expanding the introduction of PCV immunization in West Java and East Java provinces. We aim to implement PCV immunization throughout Indonesia by 2024. The implementation of the introduction of a new vaccine certainly requires the support of all parties, including international development partners.”

Indonesia formally endorsed the procurement of pneumococcal vaccines through the Gavi Advanced Market Commitment mechanism to purchase doses directly from UNICEF’s global Supply Division at a more affordable price to improve the sustainability of the national immunization programme.

“This is an important milestone for Indonesia. We know that pneumonia can be easily prevented and managed with simple and effective interventions such as immunization,” said UNICEF Representative Debora Comini. “With these pneumococcal  vaccine doses, the country is one step closer to ensuring that no child dies of a preventable cause.”

Media contacts

Kinanti Pinta Karana
Communications Specialist
UNICEF Indonesia
Tel: +62 8158805842


UNICEF promotes the rights and wellbeing of every child, in everything we do. Together with our partners, we work in 190 countries and territories to translate that commitment into practical action, focusing special effort on reaching the most vulnerable and excluded children, to the benefit of all children, everywhere.

For more information about UNICEF and its work for children, visit

Follow UNICEF on Twitter and Facebook